45 CFR § 180 compliance
F · 50
This hospital published little of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
○Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
8,477
Insurances with rates
0
CPT / HCPCS codes
36
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| ipilimumab 5 mg/mL 40mL inj lhc | ipilimumab 5 mg/mL 40mL inj lhc | $50,887 | — | — | — | 0 |
| pegloticase 8 mg/mL 1mL inj lhc | pegloticase 8 mg/mL 1mL inj lhc | $40,684 | — | — | — | 0 |
| ocrelizumab 30mg/mL 10mL inj lhc | ocrelizumab 30mg/mL 10mL inj lhc | $29,250 | — | — | — | 0 |
| paliperidone 819 mg/2.625 mL ER suspension lhc | paliperidone 819 mg/2.625 mL ER suspension lhc | $20,256 | — | — | — | 0 |
| cabazitaxel 60mg/1.5mL inj lhc | cabazitaxel 60mg/1.5mL inj lhc | $18,860 | — | — | — | 0 |
| atezolizumab 60mg/mL 20mL inj lhc | atezolizumab 60mg/mL 20mL inj lhc | $18,000 | — | — | — | 0 |
| leuprolide 45mg/6month kit lhc | leuprolide 45mg/6month kit lhc | $18,000 | — | — | — | 0 |
| lanreotide 120mg/0.5mL inj lhc | lanreotide 120mg/0.5mL inj lhc | $17,209 | — | — | — | 0 |
| brentuximab vedotin 50 mg Inject lhc | brentuximab vedotin 50 mg Inject lhc | $17,194 | — | — | — | 0 |
| alteplase 100mg vial lhc | alteplase 100mg vial lhc | $15,841 | — | — | — | 0 |
| pegfilgrastim (OnPro Neulasta) 6mg/0.6mL On-body | pegfilgrastim (OnPro Neulasta) 6mg/0.6mL On-body injector lhc | $15,702 | — | — | — | 0 |
| pegfilgrastim 6mg/0.6mL inj lhc | pegfilgrastim 6mg/0.6mL inj lhc | $15,702 | — | — | — | 0 |
| eteplirsen 50 mg/mL 10mL inj lhc | eteplirsen 50 mg/mL 10mL inj lhc | $15,049 | — | — | — | 0 |
| 5668038 | AEQ ASCEND FLEX PTC 6A 127.5__DWF606A | $14,596 | — | — | — | 0 |
| 5668047 | AEQ ASCEND FLEX SZ 5B__DWF605B | $14,596 | — | — | — | 0 |
| 5668057 | AEQ ASCEND FLEX STD SZ 6B__DWF606B | $14,596 | — | — | — | 0 |
| 5668069 | AEQ ASCEND FLEX STD SIZE 8B__DWF608B | $14,596 | — | — | — | 0 |
| 5668072 | AEQ ASCEND FLEX SZ 6C__DWF606C | $14,596 | — | — | — | 0 |
| 5668075 | AEQ ASC FLEX PTC HUM STD,7B__DWF607B | $14,596 | — | — | — | 0 |
| lanreotide 90 mg/0.3 mL Soln lhc | lanreotide 90 mg/0.3 mL Soln lhc | $14,593 | — | — | — | 0 |
| vedolizumab 300 mg vial lhc | vedolizumab 300 mg vial lhc | $13,973 | — | — | — | 0 |
| octreotide 30mg LAR inj soln lhc | octreotide 30mg LAR inj soln lhc | $13,794 | — | — | — | 0 |
| paliperidone 546 mg/1.75 mL ER suspension lhc | paliperidone 546 mg/1.75 mL ER suspension lhc | $13,479 | — | — | — | 0 |
| obinutuzumab 25 mg/mL 40mL inj lhc | obinutuzumab 25 mg/mL 40mL inj lhc | $13,405 | — | — | — | 0 |
| leuprolide 30mg kit lhc | leuprolide 30mg kit lhc | $13,389 | — | — | — | 0 |
| ramucirumab 10mg/mL 50mL inj lhc | ramucirumab 10mg/mL 50mL inj lhc | $11,985 | — | — | — | 0 |
| 5668050 | INTEGRA MATRIX WOUND DRESS__54051 | $11,740 | — | — | — | 0 |
| 5668031 | AEQUALIS HUM HEAD SHOULDER__DWF146 | $11,342 | — | — | — | 0 |
| 5668071 | FLEX SHOULDER SYS HEAD 52X23__DWF153 | $11,342 | — | — | — | 0 |
| 5668055 | AEQ REV II GLENOID 36X35__DWD182 | $11,232 | — | — | — | 0 |
| 5668066 | AEQ REV CTR GLEN SZ 42__DWD193 | $10,902 | — | — | — | 0 |
| 5988044 | AEQ REV II GLENOID BP 36__DWD180 | $10,902 | — | — | — | 0 |
| octreotide 20mg inj soln lhc | octreotide 20mg inj soln lhc | $10,747 | — | — | — | 0 |
| 5601204 | AEQUALIS HUM HEAD 46MMX17MM__DWF046 | $10,740 | — | — | — | 0 |
| ofatumumab 20mg/mL 50mL inj lhc | ofatumumab 20mg/mL 50mL inj lhc | $10,623 | — | — | — | 0 |
| tenecteplase 50mg kit lhc | tenecteplase 50mg kit lhc | $10,551 | — | — | — | 0 |
| pertuzumab 420 mg/14 mL inj lhc | pertuzumab 420 mg/14 mL inj lhc | $10,512 | — | — | — | 0 |
| benralizumab 30mg/mL 1mL inj lhc | benralizumab 30mg/mL 1mL inj lhc | $10,500 | — | — | — | 0 |
| leuprolide 22.5mg kit lhc | leuprolide 22.5mg kit lhc | $10,500 | — | — | — | 0 |
| natalizumab 20mg/mL 15mL inj lhc | natalizumab 20mg/mL 15mL inj lhc | $10,500 | — | — | — | 0 |
| pembrolizumab 100mg inj lhc | pembrolizumab 100mg inj lhc | $10,500 | — | — | — | 0 |
| riTUXimab 10mg/mL 50mL inj lhc | riTUXimab 10mg/mL 50mL inj lhc | $10,500 | — | — | — | 0 |
| trastuzumab 440mg vial MDV lhc | trastuzumab 440mg vial MDV lhc | $10,500 | — | — | — | 0 |
| leuprolide 11.25mg/3months kit lhc | leuprolide 11.25mg/3months kit lhc | $9,831 | — | — | — | 0 |
| 5600362 | POLARSTEM COLLAR LAT TI/HA 6__75018417 | $9,760 | — | — | — | 0 |
| 5600363 | POLARSTEM COLLAR LAT TI/HA 7__75018418 | $9,760 | — | — | — | 0 |
| 5600364 | POLARSTEM COLLAR LAT TI/HA 8__75018419 | $9,760 | — | — | — | 0 |
| 5600365 | POLRSTM STEM STD TI/HA 01 NO-C__75100462 | $9,760 | — | — | — | 0 |
| 5600366 | POLRSTM STEM STD TI/HA 0 NO-C__75100463 | $9,760 | — | — | — | 0 |
| 5600367 | POLRSTM STEM STD TI/HA 1 NO-C__75100464 | $9,760 | — | — | — | 0 |
Showing top 50 of 8,477 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.